Valeant defends price hikes after Clinton remarks; shares jump

(Reuters) - Shares of Valeant Pharmaceuticals International Inc jumped 6 percent on Friday, after the company responded to criticism by Democratic presidential contender Hillary Clinton over price hikes for its migraine drug.